We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AME posted Q4 EPS of $2.01, up 7.5% Y/Y, while revenues climbed 13.4% to $2.0B, topping estimates.
AMETEK saw strong segment growth, with EIG sales up 13% and EMG revenues rising 15% year over year.
AME initiated 2026 guidance, projecting mid-to-high single-digit sales growth and EPS up 6-9% Y/Y.
AMETEK, Inc. (AME - Free Report) reported fourth-quarter 2025 results, wherein both top and bottom lines surpassed the Zacks Consensus Estimate.
AMETEK reported its fourth-quarter non-GAAP earnings of $2.01 per share, beating the Zacks Consensus Estimate by 3.6%. The figure increased 7.5% year over year.
AMETEK’s top line of $2 billion surpassed the Zacks Consensus Estimate by 2.6%. The figure increased 13.4% year over year.
The company experienced an increase in sales in its largest EIG segment and a year-over-year improvement in the EMG segment.
EIG sales (68.5% of total revenue) in the fourth quarter were $1.37 billion, up 13% from the year-ago quarter’s reported figure. Our model estimate for the EIG sales was pegged at $1.33 billion.
In the fourth quarter, revenues from EMG (31.5% of total revenues) were $628.92 million, up 15% from the year-ago quarter. Our model estimate for the EMG sales was pegged at $595 million.
For the fourth quarter, operating income increased 11.5% year over year to $523 million. However, the operating margin contracted 50 basis points (bps) from the year-ago quarter.
EIG's fourth-quarter operating income was $396.1 million, and operating income margins were 28.9% in the quarter.
EMG’s operating income in the quarter increased 28% to $142.5 million with operating income margins of 22.7%, reflecting an increase of 240 bps from the year-ago reported figure.
AME’s Balance Sheet & Cash Flow
As of Dec. 31, 2025, AME had cash and cash equivalents of $457.95 million compared with the previous quarter’s $439.2 million.
As of Dec. 31, 2025, AME’s long-term debt was $1.07 billion, down from the previous quarter’s $1.43 billion.
Operating cash flow in the fourth quarter was $584.3 million, and free cash flow was $527.3 million. In 2025, it generated operating and free cash flows of approximately $1.80 billion and $1.67 billion, respectively. In the fourth quarter, the company’s free cash flow to net income conversion was 132%.
AME Initiates Guidance for 2026
For 2026, AME expects overall sales to be up mid to high single digits compared to the 2025 reported level. The Zacks Consensus Estimate is pegged at $7.92 billion, indicating a year-over-year increase of 7.9%.
The company expects its adjusted earnings per share to be in the range of $7.87-$8.07, up 6% to 9% compared with the 2025 reported level. The Zacks Consensus Estimate for earnings is pegged at $7.98 per share, indicating a year-over-year increase of 8.5%.
For the first quarter of 2026, the company expects overall sales to be up approximately 10% compared with the same period last year. The Zacks Consensus Estimate is pegged at $1.90 billion, indicating a year-over-year increase of 9.8%.
Adjusted earnings for the first quarter are expected to be in the range of $1.85-$1.90, indicating a year-over-year increase of 6-9%. The Zacks Consensus Estimate for earnings is pegged at $1.89 per share, indicating a year-over-year rise of 8%.
The Zacks Consensus Estimate for Amphenol’s earnings for 2026 has been revised upward by 2 cents to $4.32 per share over the past seven days and suggests a year-over-year increase of 29.3%. Amphenol shares have jumped 35.9% in the past six months.
The Zacks Consensus Estimate for Amtech Systems’ fiscal 2026 earnings is pegged at 43 cents per share, up from the prior estimate of 15 cents per share over the past 60 days, calling for a year-over-year surge of 760%. Amtech Systems shares have soared 290.3% in the past six months.
The Zacks Consensus Estimate for BILL Holdings’ fiscal 2026 earnings has remained unchanged at $2.21 per share over the past 60 days, suggesting no year-over-year growth. BILL Holdings shares have declined 11.2% in the past six months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
AMETEK Q4 Earnings Surpass Expectations, Revenues Rise Y/Y
Key Takeaways
AMETEK, Inc. (AME - Free Report) reported fourth-quarter 2025 results, wherein both top and bottom lines surpassed the Zacks Consensus Estimate.
AMETEK reported its fourth-quarter non-GAAP earnings of $2.01 per share, beating the Zacks Consensus Estimate by 3.6%. The figure increased 7.5% year over year.
AMETEK’s top line of $2 billion surpassed the Zacks Consensus Estimate by 2.6%. The figure increased 13.4% year over year.
The company experienced an increase in sales in its largest EIG segment and a year-over-year improvement in the EMG segment.
AMETEK, Inc. Price, Consensus and EPS Surprise
AMETEK, Inc. price-consensus-eps-surprise-chart | AMETEK, Inc. Quote
AMETEK’s Q4 2025 Details
EIG sales (68.5% of total revenue) in the fourth quarter were $1.37 billion, up 13% from the year-ago quarter’s reported figure. Our model estimate for the EIG sales was pegged at $1.33 billion.
In the fourth quarter, revenues from EMG (31.5% of total revenues) were $628.92 million, up 15% from the year-ago quarter. Our model estimate for the EMG sales was pegged at $595 million.
For the fourth quarter, operating income increased 11.5% year over year to $523 million. However, the operating margin contracted 50 basis points (bps) from the year-ago quarter.
EIG's fourth-quarter operating income was $396.1 million, and operating income margins were 28.9% in the quarter.
EMG’s operating income in the quarter increased 28% to $142.5 million with operating income margins of 22.7%, reflecting an increase of 240 bps from the year-ago reported figure.
AME’s Balance Sheet & Cash Flow
As of Dec. 31, 2025, AME had cash and cash equivalents of $457.95 million compared with the previous quarter’s $439.2 million.
As of Dec. 31, 2025, AME’s long-term debt was $1.07 billion, down from the previous quarter’s $1.43 billion.
Operating cash flow in the fourth quarter was $584.3 million, and free cash flow was $527.3 million. In 2025, it generated operating and free cash flows of approximately $1.80 billion and $1.67 billion, respectively. In the fourth quarter, the company’s free cash flow to net income conversion was 132%.
AME Initiates Guidance for 2026
For 2026, AME expects overall sales to be up mid to high single digits compared to the 2025 reported level. The Zacks Consensus Estimate is pegged at $7.92 billion, indicating a year-over-year increase of 7.9%.
The company expects its adjusted earnings per share to be in the range of $7.87-$8.07, up 6% to 9% compared with the 2025 reported level. The Zacks Consensus Estimate for earnings is pegged at $7.98 per share, indicating a year-over-year increase of 8.5%.
For the first quarter of 2026, the company expects overall sales to be up approximately 10% compared with the same period last year. The Zacks Consensus Estimate is pegged at $1.90 billion, indicating a year-over-year increase of 9.8%.
Adjusted earnings for the first quarter are expected to be in the range of $1.85-$1.90, indicating a year-over-year increase of 6-9%. The Zacks Consensus Estimate for earnings is pegged at $1.89 per share, indicating a year-over-year rise of 8%.
Zacks Rank and Other Stocks to Consider
Currently, AME carries a Zacks Rank #2 (Buy).
Amphenol (APH - Free Report) , Amtech Systems (ASYS - Free Report) and BILL Holdings, Inc. (BILL - Free Report) are some other top-ranked stocks that investors can consider in the broader Zacks Computer and Technology sector. Amphenol, Micron Technology and Lam Research sport a Zacks Rank #1 (Strong Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Amphenol’s earnings for 2026 has been revised upward by 2 cents to $4.32 per share over the past seven days and suggests a year-over-year increase of 29.3%. Amphenol shares have jumped 35.9% in the past six months.
The Zacks Consensus Estimate for Amtech Systems’ fiscal 2026 earnings is pegged at 43 cents per share, up from the prior estimate of 15 cents per share over the past 60 days, calling for a year-over-year surge of 760%. Amtech Systems shares have soared 290.3% in the past six months.
The Zacks Consensus Estimate for BILL Holdings’ fiscal 2026 earnings has remained unchanged at $2.21 per share over the past 60 days, suggesting no year-over-year growth. BILL Holdings shares have declined 11.2% in the past six months.